Shield Therapeutics plc
A de-risked commercial stage pharmaceutical company with a focus on addressing iron deficiency via its lead product Ferric Maltol, marketed in the EU as Feraccru® and approved in the US and will be marketed as Accrufer®.
David ChildsDirector of Product Supply & Commercial Alliances
Founded in 2010, Sphere Fluidics is an established Life Sciences company, originally spun out from the University of Cambridge. We initially developed 25 patented products – biochips and specialist chemicals – which currently assist hundreds of customers globally with their research.
We initially focused on producing novel biochip systems and providing R&D services. We have since extended our expertise and are developing a technology platform that enables discovery in a range of growing markets through single cell analysis. Our systems make the development of new biopharmaceuticals faster and more cost-effective, improve monoclonal antibody screening, cell line development, and overall research efficiency in a number of other applications including synthetic biology, single cell diagnostics, prognostics and single cell genome editing.
The Cyto-Mine® Single Cell Analysis System is our flagship product – the first integrated, benchtop system to automatically analyse, sort and dispense millions of individual cells in just a single day.
SQN Clinical – the biometrics partner of choice for clinical development professionals: exhibiting at booth 9.
SQN has a well-earned international reputation as a specialist data management company who can be trusted to meet the biometrics needs of your projects, while working seamlessly with your team and chosen partners. Your focus is likely to be pharmaceutical, biotechnology or medical device development; ours is to help you get your product to market as quickly and efficiently as possible – at reasonable cost with the highest confidence that it will meet regulatory needs.
For over 20 years, we’ve been taking the stress and risk out of planning, managing, analysing and reporting clinical trials. We are the preferred, trusted partner of choice for both local and internationally-based companies; we always keep our promises. The high percentage of repeat business we enjoy is testament to every member of our team going the extra mile, providing a quality service within agreed timelines and budgets, ensuring complete satisfaction.
Pauline AllenBusiness Support Manager
Lester PowellBusiness Development Manager
Therakind is a private European pharmaceutical company with the primary objective of increasing the availability of authorised speciality medicines and ensuring that these medicines are both safe and effective.
Therakind creates, develops, and improves paediatric and other speciality medicinal products and has already successfully brought two paediatric medicines and a further speciality medicine to market. An extensive pipeline of products is under development.
UK BioIndustry Association (BIA)
Established in 1989, the BIA (BioIndustry Association) exists to encourage and promote a financially sound and thriving bioscience sector within the UK economy and concentrates its efforts on emerging enterprise and the related interests of companies Founded over 20 years ago at the infancy of biotechnology, the BIA is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives. For further information, please go to www.bioindustry.org